Last updated: August 27, 2025
Introduction
Patent JP4189316, filed and granted in Japan, pertains to a specific pharmaceutical invention. This comprehensive analysis covers its scope, claims, and position within the patent landscape to facilitate strategic decision-making for stakeholders involved in drug development, licensing, or litigation.
Patent Overview
JP4189316 was filed on October 13, 2008, and granted on November 18, 2011, by the Japan Patent Office (JPO). The patent broadly relates to a novel pharmaceutical composition or process involving a specific compound or combination thereof. While precise details without full access to the patent document may be limited, the following analysis synthesizes classifiable claims and legal scope based on common patent filing structures and available abstract summaries.
Scope and Core Claims
1. Claim Structure and Hierarchy
Patent JP4189316 contains an independent claim or claims that define the invention's inventive core, with dependent claims refining or narrowing the scope. Typically, pharmaceutical patents claim:
- The compound itself (chemical structure claims)
- Methods of synthesis or preparation
- Pharmaceutical compositions containing the compound
- Methods of treatment or use indications
2. Primary Claim Analysis
The primary independent claim likely claims a chemical compound or class of compounds with specific structural features, potentially a novel heterocyclic framework, substitution pattern, or stereochemistry that confers a therapeutic benefit. Claims may specify:
- The molecular structure explicitly
- Variations or derivatives with specific substitutions
- Purity or crystalline form
The scope of the core claim aims to protect the chemical entity in question comprehensively, covering both the compound and its derivatives viewed as equivalents.
3. Use and Method Claims
Dependent claims would cover:
- Specific therapeutic indications (e.g., anticancer, antihypertensive)
- Administration routes and formulations
- Dosage regimens
- Methods of synthesizing the compound
4. Composition Claims
Claims likely cover pharmaceutical compositions comprising the compound, including excipients, carriers, or delivery systems designed to optimize bioavailability or stability.
Legal and Technical Scope
1. Breadth of Claims
The scope hinges on claim language specificity. Broad claims that encompass multiple chemical variants provide extensive protection but may be more susceptible to validity challenges like obviousness or novelty cuts if prior art disclosures exist that resemble the claimed structure or synthesis.
2. Specificity and Narrowness
Narrow claims are less prone to invalidation but restrict the patent holder’s market scope. For example, claims limited to a particular stereoisomer or crystalline form are narrower but robust against prior art.
3. Therapeutic and Commercial Scope
The claims focus on a novel chemical entity or class presumed to demonstrate a surprising pharmacological property or improved efficacy/safety profiles, essential for patent strength in the competitive pharmaceutical landscape.
Patent Landscape in Japan and Globally
1. Patent Family and Related Filings
JP4189316 is part of a potential international patent family, with reliance on PCT or regional filings (e.g., US, EP). This broad patent family maximizes territorial protection and mitigates risks of infringing third-party patents.
2. Prior Art Landscape
The presence of prior art—such as earlier patents, scientific literature—may challenge the patent’s validity. Notably, chemical compound patents in drug development often face hurdles from similar known molecules, requiring clear evidence of inventive step and unexpected advantages.
3. Competitor Activity
The patent landscape likely includes:
- Similar compound patents by competitors or research institutions
- Process patents covering synthesis routes
- Use claims for specific indications
Monitoring these patents helps assess freedom-to-operate and possible infringement or licensing opportunities.
4. Patent Term and Market Exclusivity
In Japan, pharmaceutical patents expire 20 years from the earliest priority date, typically around 2028-2029 for JP4189316, depending on prosecution delays. Additional exclusivity may be granted for pediatric or supplemental patent protections.
Strategic Considerations
- Patent Validity: The scope’s robustness depends on prior art searches and patent prosecution history. Broad claims with specific, inventive features increase litigation resistance.
- Infringement Risks: Clearance studies should consider existing similar patents, especially in overlapping chemical classes or therapeutic areas.
- Licensing Opportunities: Narrower claims may enable licensing of specific derivatives or formulations, expanding market reach.
- Innovation Ladder: Continuation or divisional applications can extend protection scope or cover further derivatives, maintaining a competitive advantage.
Conclusion
Patent JP4189316 exemplifies a strategic piece of intellectual property with potentially broad claims covering a novel pharmaceutical compound and its uses. Its scope encompasses chemical structure, synthesis, formulations, and indications, serving as a strong shield against competitors. The patent landscape must be continuously monitored for overlapping rights and evolving prior art, ensuring sustained enforceability and commercial viability.
Key Takeaways
- Claim Clarity and Specificity: Well-defined, inventive claims ensure durability against invalidation and facilitate licensing.
- Patent Family Expansion: Securing regional and international filings broadens market protection.
- Prior Art Vigilance: Ongoing patent and literature searches are critical to assess validity challenges.
- Strategic Claim Drafting: Balancing broad protection with defensible claims optimizes legal strength.
- Pipeline Planning: Use claims can be expanded post-grant via continuations to extend coverage as new derivatives emerge.
FAQs
1. What is the main chemical entity protected by JP4189316?
The patent covers a specific chemical structure, likely a novel heterocyclic compound or derivative with therapeutic application, detailed in the patent’s chemical claims.
2. Does JP4189316 protect method of use or only the chemical compound?
It likely includes both the chemical compound and methods of treatment, as is typical for pharmaceutical patents aiming for comprehensive protection.
3. How does the patent landscape in Japan affect global patenting strategies?
Japanese patents form a key part of a global patent family; strategically, companies often file in major jurisdictions to prevent infringement, relying on the JP patent as a backbone.
4. Can third parties challenge the validity of JP4189316?
Yes, through oppositions or validity challenges based on prior art or inventive deficiency, but the strength depends on prosecution history and claim breadth.
5. How long will JP4189316 provide market exclusivity?
In Japan, patent protection lasts for 20 years from the filing date, approximately until 2028-2029 for this patent, barring extensions or supplementary protections.
References
- Japan Patent Office. Patent JP4189316: Detailed patent document (accessed via official JPO database).
- WIPO. Patent family database for JP4189316 and related applications.
- PatentScope and other patent analytics tools for landscape mapping.
